Monthly Communication Report

Corporation:	Novartis Pharmaceuticals Canada Inc.
Associated registration:	957165-15599-39
Communication date:	2025-03-19
Posted date:	2025-04-15

Designated Public Office Holders who participated in the communication:	Sarah Lawley, Assistant Deputy Minister Health Policy Branch, Health Canada (HC) Pamela Aung-Thin, Assistant Deputy Minister Health Products and Food Branch, Health Canada (HC)
List of Details Subject matter Detail Health, Industry Federal Innovation agenda. Working with our Industry Associations (Innovative Medicines Canada and BIOTECanada) to ensure that innovative medicines, and our contribution to Research and Development in Canada are part of the consultation process in the development of this new innovation agenda. Health, Industry Working with our Industry Associations (Innovative Medicines Canada and BIOTECanada) to provide industry recommendations on Canada's Biomanufacturing and Life Sciences Strategy, National Pharmacare, Intellectual property as well as pricing reforms (PMPRB)
Responsible Officer who filed this communication report:	Mark Vineis
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.